ArticleJournal of the National Cancer Institute2018

Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women.

Ranjit Manchanda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.